SCHEMBL926976

SCHEMBL926976

CC(C)(C)c1ccc(S(=O)(=O)N2c3ccccc3C[C@H]2C(=O)NCCc2ccccc2Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.46
EPHX2 P34913 1/20 0.43
ALDH1A1 P00352 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
GAA P10253 1/20 0.42
GNRHR P30968 1/20 0.42
RORC P51449 1/20 0.41
PKM P14618 2/20 0.40
PLA2G1B P04054 1/20 0.40
ATG4B Q9Y4P1 1/20 0.40
PSEN1 P49768 1/20 0.40
PSEN2 P49810 1/20 0.40
APH1B Q8WW43 1/20 0.40
NCSTN Q92542 1/20 0.40
APH1A Q96BI3 1/20 0.40
PSENEN Q9NZ42 1/20 0.40
PTGER3 P43115 1/20 0.40
LMNA P02545 1/20 0.40
GLA P06280 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL927221 0.91 EPHX2 (0.52) HSD11B1EPHX2ALDH1A1RORCPSEN1
SCHEMBL926071 0.91 HSD11B1 (0.46) HSD11B1EPHX2ALDH1A1RORCPKM
SCHEMBL926737 0.90 LMNA (0.46) HSD11B1ALDH1A1GAARORCPKM
SCHEMBL926180 0.89 LMNA (0.48) HSD11B1ALDH1A1L3MBTL1RORCPKM
SCHEMBL927527 0.88 FKBP1A (0.48) ALDH1A1RORCPKMPSEN1PSEN2
SCHEMBL928273 0.88 MAPT (0.49) ALDH1A1RORCLMNASMN1; SMN2MAPT
SCHEMBL928733 0.88 PSEN1 (0.51) HSD11B1ALDH1A1GAAPSEN1PSEN2
SCHEMBL926338 0.87 FKBP1A (0.49) ALDH1A1GAAPSEN1PSEN2APH1B
SCHEMBL926670 0.87 BDKRB1 (0.44) HSD11B1EPHX2ALDH1A1GAARORC
SCHEMBL926406 0.86 FKBP1A (0.47) ALDH1A1PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7872021-B2 LXR receptor modulators LABORATORIES FOURNIER S.A. (FR) 2011-01-18 US disclosed
US-20070099960-A1 LXR receptor modulators LABORATOIRES FOURNIER S.A. (FR) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099960-A1 LXR receptor modulators NR1H2, NR1H3, PPARD HSD11B1 78/4885EPHX2 3088/4885ALDH1A1 2845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.